Abstract
The response of living tissue to injury is characterized by an increase in blood flow and a local influx of leukocytes. These events, mediated by either the upregulation or induction of adhesion molecules and the release of biologically active substances, are collectively termed inflammation. The inflammatory response is not antigen-specific and occurs following all modes of tissue injury, including traumatic, ischemic, and infectious insults. In infection, the inflammatory response is usually accompanied by an immune response, which is antigen specific. The brain has traditionally been regarded as an immunologically privileged organ, but it is subject to continuous lymphocyte surveillance and inflammatory and immunological reactions do occur in the brain. The character of the inflammatory response in the brain, however, differs from that of other organs. These differences result from the fact that under normal circumstances, the blood-brain barrier (BBB) exists and the cerebral microvessels express few of the adhesion molecules required for leukocyte trafficking into the brain. But when the brain is injured, the BBB becomes compromised (Belayev et al. 1996) and there is an upregulation of leukocyte adhesion molecules, both of which allow for an inflammatory response, and potentially an immune response, to occur.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akassoglou K, Probert L, Kontogeorgos, G, Kollias G (1997) Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 158:438–445
Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ, Murphy G (1998) TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435:39–44
Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G, D’Alessandro R (1995) Fever in acute stroke worsens prognosis. A prospective study. Stroke 26: 2040–2043
Baldwin AS Jr (1996) The NF-κB and I κB proteins: new discoveries and insights. Annu Rev Immunol 14:649–683
Barger SW, Harmon AD (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388:878–881
Barkalow FJ, Goodman MJ, Gerritsen ME, Mayadas TN (1996) Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion. Blood 88: 4585–4593
Barnum SR (1995) Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 6:132–146
Barnum SR, Jones JL, Muller-Ladner U, Samimi A, Campbell IL (1996) Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression. Glia 18:107–117
Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-α. A mediator of focal ischemic brain injury. Stroke 28:1233–1244
Barone FC, White RF, Spera, PA, Ellison J, Currie RW, Wang X, Feuerstein GZ (1998) Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29:1937–1950
Bazan NG, Allan G (1996) Platelet-activating factor in the modulation of excitatory amino acid neurotransmitter release and of gene expression. J Lipid Mediat Cell Signal 14:321–330
Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717–1725
Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR (1995) Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 37:800–805
Becker K, Kindrick D, Relton J, Harlan J, Winn R (2001) Antibody to the alpha 4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32:206–211
Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM (1997) Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci USA 94:10873–10978
Bednar MM, Gross CE, Russell SR, Fuller SP, Ellenberger CL, Schindler E, Klingbeil C, Vexier V (1998) Humanized anti-L-selectin monoclonal antibody DREG200 therapy in acute thromboembolic stroke. Neurol Res 20:403–408
Bednar MM, Raymond S, McAuliffe T, Lodge PA, Gross CE (1991) The role of neutrophils and platelets in a rabbit model of thromboembolic stroke. Stroke 22:44–50
Belayev L, Busto R, Zhao W, Ginsberg MD (1996) Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739:88–96
Bell MD, Perry VH (1995) Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J Neurocytol 24:695–710
Bellander BM, von Holst H, Fredman P, Svensson M (1996) Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat. J Neurosurg 85:468–475
Benigni F, Faggioni R, Sironi M, Fantuzzi G, Vandenabeele P, Takahashi N, Sacco S, Fiers W, Buurman WA, Ghezzi P (1996) TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracere-broventricular injection of TNF. J Immunol 157:5563–5568
Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ (1995) Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91:2488–2496
Betz AL, Yang GY, Davidson BL (1995) Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 15:547–551
Bolton SJ, Anthony DC, Perry VH (1998) Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86:1245–1257
Bonventre JV (1997) Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity. J Lipid Mediat Cell Signal 16:199–208
Botchkina GI, Meistrell ME 3rd, Botchkina IL, Tracey KJ (1997) Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 3:765–781
Brayton J, Qing Z, Hart MN, VanGilder JC, Fabry Z (1998) Influence of adhesion molecule expression by human brain microvessel endothelium on cancer cell adhesion. J Neuroimmunol 89:104–112
Brett FM, Mizisin AP, Powell HC, Campbell IL (1995) Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 54:766–775
Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2:788–794
Cao C, Matsumura K, Watanabe Y (1997). Induction of cyclooxygenase-2 in the brain by cytokines. Ann NY Acad Sci 813:307–309
Carlos TM, Clark RS, Franicola-Higgins D, Schiding JK, Kochanek PM (1997) Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats. J Leukoc Biol 61:279–285
Carp H (1982) Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 155:264–275
CAST Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischemic stroke. Lancet 349:1641–1649
Castillo J, Davalos A, Marrugat J, Noya M (1998) Timing for fever-related brain damage in acute ischemic stroke. Stroke 29:2455–2460
Chen H, Chopp M, Zhang RL, Bodzin G, Chen Q, Rusche JR, Todd RF 3rd (1994) Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann Neurol 35:458–463
Cheng B, Christakos S, Mattson MP (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12:139–153
Chopp M, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR (1994) Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25:869–875
Clark WM, Calcagno FA, Gabler WL, Smith JR, Coull BM (1994) Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment. Stroke 25:1411–1415
Clark WM, Coull BM, Briley DP, Mainolfi E, Rothlein R (1993) Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke. J Neuroimmunol 44:123–125
Clark WM, Lauten JD, Lessov N, Woodward W, Coull BM (1995) Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol Chem Neuropathol 26:213–230
Clemens JA, Stephenson DT, Smalstig EB, Dixon EP, Little SP (1997) Global ischemia activates nuclear factor-κB in forebrain neurons of rats. Stroke 28:1073–1080
Clemens JA, Stephenson DT, Smalstig EB, Roberts EF, Johnstone EM, Sharp JD, Little SP, Kramer RM (1996) Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke 27:527–535
Cole DJ, Patel PM, Schell RM, Drummond JC, Osborne TN (1993) Brain eicosanoid levels during temporary focal cerebral ischemia in rats: a microdialysis study. J Neurosurg Anesthesiol 5:41–47
Corvin S, Schurer L, Abels C, Kempski O, Baethmann A (1990) Effect of stimulation of leukocyte Chemotaxis by fMLP on white blood cell behaviour in the microcirculation of rat brain. Acta Neurochir Suppl 51:55–57
Davies C, Loddick S, Toulmond S, Stroemer R, Hunt J, Rothwell N (1999) The progression and topographic distribution of interleukin-1β expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 19:87–98
Dawson DA, Martin D, Hallenbeck JM (1996a) Inhibition of tumor necrosis factor-α reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 218:41–44
Dawson DA, Ruetzler CA, Carlos TM, Kochanek PM, Hallenbeck JM (1996b) Polymorphonuclear leukocytes and microcirculatory perfusion in acute stroke in the SHR. Keio J Med 45:248–252
De Bleecker J, Coulier I, Fleurinck C, De Reuck J (1998) Circulating intercellular adhesion molecule-1 and E-selectin in acute ischemic stroke. J Stroke Cerebrovasc Dis 7:192–195
De Simoni MG, De Luigi A, Gemma L, Sironi M, Manfridi A, Ghezzi P (1993) Modulation of systemic interleukin-6 induction by central interleukin-1. Am J Physiol 265:R739–R742
DeGraba TJ (1997) Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque. Neurology 49:S15–S19
del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM (1991) Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22:1276–1283
Deluga KS, Plotz FB, Betz AL (1991) Effect of indomethacin on edema following single and repetitive cerebral ischemia in the gerbil. Stroke 22:1259–1264
Dempsey RJ, Roy MW, Cowen DE, Maley ME (1986) Lipoxygenase metabolites of arachidonic acid and the development of ischaemic cerebral oedema. Neurol Res 8:53–56
Ehrlich LC, Hu S, Sheng WS, Sutton RL, Rockswold GL, Peterson PK, Chao CC (1998) Cytokine regulation of human microglial cell IL-8 production. J Immunol 160: 1944–1948
Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgarde F, Ohlsson K (1996) Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 27:1734–1738
Ember JA, Sanderson SD, Hugh TE, Morgan EL (1994) Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol 144:393–403
Ericsson A, Liu C, Hart RP, Sawchenko PE (1995) Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361:681–698
Farrar WL, Kilian PL, Ruff MR, Hill JM, Pert CB (1987) Visualization and characterization of interleukin 1 receptors in brain. J Immunol 139:459–463
Fassbender K, Mossner R, Motsch L, Kischka U, Grau A, Hennerici M (1995) Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 26:1361–1364
Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M (1994) Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 122:135–139
Fattori E, Lazzaro D, Musiani P, Modesti A, Alonzi T, Ciliberto G (1995) IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci 7:2441–2449
Fiszer U, Korczak-Kowalska G, Palasik W, Korlak J, Gorski A, Czlonkowska A (1998) Increased expression of adhesion molecule CD18 (LFA-1β) on the leukocytes of peripheral blood in patients with acute ischemic stroke. Acta Neurol Scand 97:221–224
Flanders KC, Ren RF, Lippa CF (1998). Transforming growth factor-βs in neurodegenerative disease. Prog Neurobiol 54:71–85
Frank MM, Fries LF (1991) The role of complement in inflammation and phagocytosis. Immunol Today 12:322–326
Fraticelli A, Serrano CV Jr, Bochner BS, Capogrossi MC, Zweier JL (1996) Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leukocyte endothelial adhesion. Biochim Biophys Acta 1310:251–259
Frenette PS, Wagner DD (1996a) Adhesion Molecules-Part I. N Engl J Med 334:1526–1529
Frenette PS, Wagner DD (1996b) Adhesion molecules-Part II: Blood vessels and blood cells. N Engl J Med 335:43–45
Gadient RA, Otten UH (1997) Interleukin-6 (IL-6) — a molecule with both beneficial and destructive potentials. Prog Neurobiol 52:379–390
Garcia JH, Liu KF, Relton JK (1995) Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 147:1477–1486
Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, del Zoppo GJ (1994) Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 144:188–199
Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP (1998) Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18:1283–1287
Gasque P, Chan P, Fontaine M, Ischenko A, Lamacz M, Gotze O, Morgan BP (1995) Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J Immunol 155:4882–4889
Gasque P, Singhrao SK, Neal JW, Wang P, Sayah S, Fontaine M, Morgan BP (1998) The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J Immunol 160:3543–3554
Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL et al. (1994) Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370:555–557
Gemma C, Imeri L, de Simoni MG, Mancia M (1997) Interleukin-1 induces changes in sleep, brain temperature, and serotonergic metabolism. Am J Physiol 272:R601–R606
Giulian D, Baker TJ, Shih LC, Lachman LB (1986) Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 164:594–604
Giulian D, Corpuz M, Richmond B, Wendt E, Hall ER (1996) Activated microglia are the principal glial source of thromboxane in the central nervous system. Neurochem Int 29:65–76
Gordon LB, Nolan SC, Ksander BR, Knopf PM, Harling-Berg CJ (1998) Normal cerebrospinal fluid suppresses the in vitro development of cytotoxic T cells: role of the brain microenvironment in CNS immune regulation. J Neuroimmunol 88:77–84
Grau AJ, Berger E, Sung KL, Schmid-Schonbein GW (1992) Granulocyte adhesion, deformability, and superoxide formation in acute stroke. Stroke 23:33–39
Grau AJ, Buggle F, Becher H, Werle E, Hacke W (1996) The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 82:245–255
Grice SC, Chappell ET, Prough DS, Whitley JM, Su M, Watkins WD (1987) Ibuprofen improves cerebral blood flow after global cerebral ischemia in dogs. Stroke 18:787–791
Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274:1383–1385
Grogaard B, Schurer L, Gerdin B, Arfors KE (1989) Delayed hypoperfusion after incomplete forebrain ischemia in the rat. The role of polymorphonuclear leukocytes. J Cereb Blood Flow Metab 9:500–505
Gross CE, Bednar MM, Howard DB, Sporn MB (1993) Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke 24:558–562
Gruol DL, Nelson TE (1997) Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15:307–339
Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Blennow M, Holst M, McRae A, Soder O (1996) Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 40:603–609
Hallenbeck JM, Furlow TW Jr (1979) Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog. Stroke 10:629–637
Hamann GF, Okada Y, del Zoppo G J (1996) Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab 16:1373–1378
Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J, Moskowitz MA (1997) Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94:2007–2012
Haring HP, Berg EL, Tsurushita N, Tagaya M, del Zoppo GJ (1996) E-selectin appears in nonischemic tissue during experimental focal cerebral ischemia. Stroke 27:1386–1391
Henrich-Noack P, Prehn JH, Krieglstein J (1994) Neuroprotective effects of TGF-β1. J Neural Transm [Suppl] 43:33–45
Henrich-Noack P, Prehn JHM, Krieglstein J (1996) TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke 27:1609–1614
Heo J, Lucero J, Abumiya T, Koziol J, Copeland B, del Zoppo GJ (1999) Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19:624–633
Hernandez J, Molinero A, Campbell IL, Hidalgo J (1997) Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice. Brain Res Mol Brain Res 48:125–131
Hess DC, Zhao W, Carroll J, McEachin M, Buchanan K (1994) Increased expression of ICAM-1 during reoxygenation in brain endothelial cells. Stroke 25:1463–1467
Howard EF, Chen Q, Cheng C, Carroll JE, Hess D (1998) NF-κB is activated and ICAM-1 gene expression is upregulated during reoxygenation of human brain endothelial cells. Neurosci Lett 248:199–203
Huang YH, Haegerstrand A, Frostegard J (1996) Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity. Clin Exp Immunol 103:61–66
Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96:4219–4225
Iijima T, Sawa H, Shiokawa Y, Saito I, Ishii H, Nakamura Z, Sankawa H (1996) Thromboxane synthetase inhibitor ameliorates delayed neuronal death in the CA1 sub-field of the hippocampus after transient global ischemia in gerbils. J Neurosurg Anesthesiol 8:237–242
Imura Y, Kiyota Y, Nagai Y, Nishikawa K, Terashita Z (1995) Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model. Thromb Res 79:95–107
International Stroke Trial Collaborative Group (1997) The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet 349:1569–1581
Irani DN, Griffin DE (1996) Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J Immunol 156:3850–3857
Irani DN, Lin KI, Griffin DE (1996) Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J Immunol 157:4333–4340
Jander S, Pohl J, Gillen C, Schroeter M, Stoll G (1996) Vascular cell adhesion molecule-1 mRNA is expressed in immune-mediated and ischemic injury of the rat nervous system. J Neuroimmunol 70:75–80
Jander S, Sitzer M, Schumann R, Schroeter M, Siebler M, Steinmetz H, Stoll G (1998) Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 29:1625–1630
Johshita H, Asano T, Hanamura T, Takakura K (1989) Effect of indomethacin and a free radical scavenger on cerebral blood flow and edema after cerebral artery occlusion in cats. Stroke 20:788–794
Kaiman J, Juhasz A, Laird G, Dickens P, Jardanhazy T, Rimanoczy A, Boncz I, Parry-Jones WL, Janka Z (1997) Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer’s disease. Acta Neurol Scand 96:236–240
Kanda T, Yamawaki M, Ariga T, Yu RK (1995) Interleukin 1 β upregulates the expression of sulfoglucuronosyl paragloboside, a ligand for L-selectin, in brain microvascular endothelial cells. Proc Natl Acad Sci USA 92:7897–7901
Kehrl J (1991) Transforming growth factor-β: an important mediator of immunoregu-lation. Int J Cell Cloning 9:438–450
Kempski O, Shohami E, von Lubitz D, Hallenbeck JM, Feuerstein G (1987) Postishemic production of eicosanoids in gerbil brain. Stroke 18:111–119
Kim JS, Chopp M, Chen H, Levine SR, Carey JL, Welch KM (1995) Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks. J Neurol Sci 128:45–50
Kim JS, Yoon SS, Kim YH, Ryu JS (1996) Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke 27:1553–1557
King C, Davies J, Mueller R, Lee MS, Krahl T, Yeung B, O’Connor E, Sarvetnick N (1998) TGF-β1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 8:601–613
Kitamura H, Okamoto S, Shimamoto Y, Morimatsu M, Terao A, Saito M (1998) Central IL-1 differentially regulates peripheral IL-6 and TNF synthesis. Cell Mol Life Sci 54:282–287
Klir JJ, Roth J, Szelenyi Z, McClellan JL, Kluger MJ (1993) Role of hypothalamic interleukin-6 and tumor necrosis factor-alpha in LPS fever in rat. Am J Physiol 265:R512–517
Kostulas N, Kivisakk P, Huang Y, Matusevicius D, Kostulas V, Link H (1998) Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 29:462–466
Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM (1993) Some remarks on the growth-rate and angiogenesis of microvessels in ischemic stroke. Morphometric and immunocytochemical studies. Patol Pol 44:203–209
Lassmann H (1997) Basic mechanisms of brain inflammation. J Neural Transm [Suppl] 50:183–190
Lavine SD, Hofman FM, Zlokovic BV (1998) Circulating antibody against tumor necrosis factor-α protects rat brain from reperfusion injury. J Cereb Blood Flow Metab 18:52–58
Ley K (1996) Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 32:733–742
Ley K, Baker JB, Cybulsky MI, Gimbrone MA Jr, Luscinskas FW (1993) Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol 151:6347–6357
Lindsberg PJ, Carpen O, Paetau A, Karjalainen-Lindsberg M-L, Kaste M (1996a) Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Stroke 94:939–945
Lindsberg PJ, Ohman J, Lehto T, Karjalainen-Lindsberg ML, Paetau A, Wuorimaa T, Carpen O, Kaste M, Meri S (1996b) Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol 40:587–596
Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-α expression in ischemic neurons. Stroke 25:1481–1488
Liu XH, Eun BL, Silverstein FS, Barks JD (1996) The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr Res 40:797–803
Loddick SA, Turnbull AV, Rothwell NJ (1998) Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18:176–179
Loddick SA, Wong ML, Bongiorno PB, Gold PW, Licinio J, Rothwell NJ (1997) Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem Biophys Res Commun 234:211–215
Luheshi GN, Stefferl A, Turnbull AV, Dascombe MJ, Brouwer S, Hopkins SJ, Rothwell NJ (1997) Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-α in the rat. Am J Physiol 272:R862–R868
Mackenzie IR, Munoz DG (1998) Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50:986–990
Macko R, Ameriso S, Barndt R, Clough W, Weiner J, Fisher M (1996) Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke 27:1999–2004
Madri JA, Graesser D, Haas T (1996) The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. Biochem Cell Biol 74:749–757
Maenpaa A, Kovanen PE, Paetau A, Jaaskelainen J, Timonen T (1997) Lymphocyte adhesion molecule ligands and extracellular matrix proteins in gliomas and normal brain: expression of VCAM-1 in gliomas. Acta Neuropathol (Berl) 94: 216–225
Mantovani A (1997) The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment. Drugs 54 [Suppl 1]: 15–23
Matsukawa A, Fukumoto T, Maeda T, Ohkawara S, Yoshinaga M (1997) Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health. Cytokine 9:307–315
Matsumoto T, Ikeda K, Mukaida N, Harada A, Matsumoto Y, Yamashita J, Matsushima K (1997) Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest 77:119–125
Matsuo Y, Kihara T, Ikeda M, Ninomiya M, Onodera H, Kogure K (1996) Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain. Brain Res 709:296–302
McGeehan GM, Becherer JD, Bast RC Jr, Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S et al. (1994) Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370:558–561
McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology 47:425–432
McKeating EG, Andrews PJ, Signorini DF, Mascia L (1997) Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth 78:520–523
Meda L, Cassatella MA, Szendrei Gl, Otvos L Jr, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374:647–650
Mehta A, Yang B, Khan S, Hendricks JB, Stephen C, Mehta JL (1995) Oxidized low-density lipoproteins facilitate leukocyte adhesion to aortic intima without affecting endothelium-dependent relaxation. Role of P-selectin. Arterioscler Thromb Vasc Biol 15:2076–2083
Miller AJ, Hopkins SJ, Luheshi GN (1997a) Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat. Br J Pharmacol 120:1274–1279
Miller DK, Myerson J, Becker JW (1997b) The interleukin-1 β converting enzyme family of cysteine proteases. J Cell Biochem 64:2–10
Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M (1992) Induction of interleukin-1 β mRNA in rat brain after transient forebrain ischemia. J Neurochem 58:390–392
Minamisawa H, Terashi A, Katayama Y, Kanda Y, Shimizu J, Shiratori T, Inamura K, Kaseki H, Yoshino Y (1988) Brain eicosanoid levels in spontaneously hypertensive rats after ischemia with reperfusion: leukotriene C4 as a possible cause of cerebral edema. Stroke 19:372–377
Mori E, del Zoppo GJ, Chambers JD, Copeland BR, Arfors KE (1992) Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 23:712–718
Morikawa E, Zhang SM, Seko Y, Toyoda T, Kirino T (1996) Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin. Stroke 27:951–955
Muller WA (1995) The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukoc Biol 57:523–528
Namura Y, Shio H, Kimura J (1994) LTC4/LTB4 alterations in rat forebrain ischemia and reperfusion and effects of AA-861, CV-3988. Acta Neurochir [Suppl] 60:296–299
Navratil E, Couvelard A, Rey A, Henin D, Scoazec JY (1997) Expression of cell adhesion molecules by microvascular endothelial cells in the cortical and subcortical regions of the normal human brain: an immunohistochemical analysis. Neuropathol Appl Neurobiol 23:68–80
Nawashiro H, Martin D, Hallenbeck JM (1997a) Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 17:229–232
Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997b) TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17:483–490
Nishida K, Markey SP (1996) Platelet-activating factor in brain regions after transient ischemia in gerbils. Stroke 27:514–518
Norgard KE, Han H, Powell L, Kriegler M, Varki A, Varki NM (1993) Enhanced interaction of L-selectin with the high endothelial venule ligand via selectively oxidized sialic acids. Proc Natl Acad Sci USA 90:1068–1072
Ohtsuki T, Ruetzler CA, Tasaki K, Hallenbeck JM (1996) Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CAI neurons. J Cereb Blood Flow Metab 16:1137–1142
Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, del Zoppo GJ (1994) P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25:202–211
O’Neill LA, Kaltschmidt C (1997) NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252–258
O’Neill PA, Davies I, Fullerton KJ, Bennett D (1991) Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 22:842–847
Parnet P, Amindan S, Wu C, Brunke-Reese D, Goujon E, Weyhenmeyer JA, Dantzer R, Kelley KW (1994) Expression of type I and type II interleukin-1 receptors in mouse brain. Brain Res Mol Brain Res 27:63–70
Patel PM, Drummond JC, Sano T, Cole DJ, Kalkman CJ, Yaksh TL (1993) Effect of ibuprofen on regional eicosanoid production and neuronal injury after forebrain ischemia in rats. Brain Res 614:315–324
Perry VH (1998) A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J Neuroimmunol 90:113–121
Pettigrew LC, Grotta JC, Rhoades HM, Wu KK (1989) Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain. Stroke 20: 627–632
Pettigrew LC, Meyer JJ, Craddock SD, Butler SM, Tai HH, Yokel RA (1995) Delayed elevation of platelet activating factor in ischemic hippocampus. Brain Res 691:243–247
Quagliarello VJ, Wispelwey B, Long WJ Jr, Scheid WM (1991) Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 87:1360–1366
Ramsay SC, Weiller C, Myers R, Cremer JE, Luthra SK, Lammertsma AA, Frackowiak RS (1992) Monitoring by PET of macrophage accumulation in brain after ischaemic stroke. Lancet 339:1054–1055
Reith J, Jorgensen H, Pedersen P, Nakayama H, Raaschou H, Jeppesen L, Olsen T (1996) Body temperature in acute stroke: relation to stroke severity, infarct size, and mortality. Lancet 347:422–425
Relton J, Sloan, KE, Frew EM, Whalley ET, Adams SP, Lobb RR (2001) Stroke 32: 199–205
Relton JK, Martin D, Thompson RC, Russell DA (1996) Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp Neurol 138:206–213
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979
Rohde LE, Lee RT, Rivero J, Jamacochian M, Arroyo LH, Briggs W, Rifai N, Libby P, Creager MA, Ridker PM (1998) Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 18:1765–1770
Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metallo-proteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020–1030
Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE (1995) Free radicals and phagocytic cells. FASEB J 9:200–209
Rosenman SJ, Shrikant P, Dubb L, Benveniste EN, Ransohoff RM (1995) Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J Immunol 154:1888–1899
Rother M, Erkinjuntti T, Roessner M, Kittner B, Marcusson J, Karlsson I (1998) Propentofylline in the treatment of Alzheimer’s disease and vascular dementia: a review of phase III trials. Dement Geriatr Cogn Disord 9 [Suppl 1]: 36–43
Rupalla K, Allegrini PR, Sauer D, Wiessner C (1998) Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice. Acta Neuropathol (Berl) 96:172–178
Sadoshima S, Ooboshi H, Okada Y, Yao H, Ishitsuka T, Fujishima M (1989) Effect of thromboxane synthetase inhibitor on cerebral circulation and metabolism during experimental cerebral ischemia in spontaneously hypertensive rats. Eur J Pharmacol 169:75–83
Sairanen TR, Lindsberg PJ, Brenner M, Siren AL (1997) Global forebrain ischemia results in differential cellular expression of interleukin-1β (IL-1β) and its receptor at mRNA and protein level. J Cereb Blood Flow Metab 17:1107–1120
Saito K, Suyama K, Nishida K, Sei Y, Basile AS (1996) Early increases in TNF-α, IL-6 and IL-1 β levels following transient cerebral ischemia in gerbil brain. Neurosci Lett 206:149–152
Salminen A, Liu PK, Hsu CY (1995) Alteration of transcription factor binding activities in the ischemic rat brain. Biochem Biophys Res Commun 212:939–944
Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522–524
Satoh K, Imaizumi T, Yoshida H, Hiramoto M, Takamatsu S (1992) Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. Acta Neurol Scand 85:122–127
Schielke GP, Yang GY, Shivers BD, Betz AL (1998) Reduced ischemic brain injury in interleukin-1 β converting enzyme-deficient mice. J Cereb Blood Flow Metab 18:180–185
Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO (1998) A neuromodulatory role of interleukin-1β in the hippocampus. Proc Natl Acad Sci USA 95:7778–7783
Schobitz B, de Kloet ER, Sutanto W, Holsboer F (1993) Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci, 5:1426–1435
Schroeter M, Jander S, Witte OW, Stoll G (1994) Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol 55:195–203
Sebire G, Emilie D, Wallon C, Hery C, Devergne O, Delfraissy JF, Galanaud P, Tardieu M (1993) In vitro production of IL-6, IL-1 β, and tumor necrosis factor-α by human embryonic microglial and neural cells. J Immunol 150:1517–1523
Shyu KG, Chang H, Lin CC (1997) Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke. J Neurol 244:90–93
Sims JE, Giri JG, Dower SK (1994) The two interleukin-1 receptors play different roles in IL-1 actions. Clin Immunol Immunopathol 72:9–14
Sornas R, Ostlund H, Muller R (1972). Cerebrospinal fluid cytology after stroke. Arch Neurol 26:489–501
Stanimirovic DB, Wong J, Shapiro A, Durkin JP (1997) Increase in surface expression of ICAM-1, VCAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults. Acta Neurochir Suppl (Wien) 70:12–16
Stella N, Estelles A, Siciliano J, Tence M, Desagher S, Piomelli D, Glowinski J, Premont J (1997) Interleukin-1 enhances the ATP-evoked release of arachidonic acid from mouse astrocytes. J Neurosci 17:2939–2946
Stewart WF, Kawas C, Corrada M, Metter EJ (1997) Risk of Alzheimer’s disease and duration of NSAID use. Neurology 48:626–632
Stins MF, Gilles F, Kim KS (1997) Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 76:81–90
Stroemer RP, Rothwell NJ (1998) Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1β in the rat. J Cereb Blood Flow Metab 18:833–839
Suzuki H, Abe K, Tojo S, Kimura K, Mizugaki M, Itoyama Y (1998). A change of P-selectin immunoreactivity in rat brain after transient and permanent middle cerebral artery occlusion. Neurol Res 20:463–469
Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26:1393–1398
Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A (1997) Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 110:492–499
Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res 748:267–270
Taylor AW, Streilein JW (1996) Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid. Neuroimmunomodulation 3:112–118
Terai K, Matsuo A, McGeer EG, McGeer PL (1996) Enhancement of immunoreactivity for NF-κB in human cerebral infarctions. Brain Res 739:343–349
The Enlimomab Acute Stroke Trial Investigators (1997) The Enlimomab acute stroke trial: final results. Neurology 48:A270:S33.001
Tokutomi T, Sigemori M, Kikuchi T, Hirohata M (1994) Effect of platelet-activating factor antagonist on brain injury in rats. Acta Neurochir [Suppl] 60:508–510
Tracey F, Crawford VL, Lawson JT, Buchanan KD, Stout RW (1993) Hyperglycaemia and mortality from acute stroke. Q J Med 86:439–446
Uno H, Matsuyama T, Akita H, Nishimura H, Sugita M (1997) Induction of tumor necrosis factor-α in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab 17:491–499
Van Dam AM, De Vries HE, Kuiper J, Zijlstra FJ, De Boer AG, Tilders FJ, Berkenbosch F (1996) Interleukin-1 receptors on rat brain endothelial cells: a role in neuroimmune interaction? FASEB J 10:351–356
Vivien D, Bernaudin M, Buisson A, Divoux D, MacKenzie ET, Nouvelot A (1998) Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia. J Neurochem 70:2296–2304
Wang WC, Goldman LM, Schleider DM, Appenheimer MM, Subjeck JR, Repasky EA, Evans SS (1998) Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J Immunol 160:961–969
Wang X, Barone FC, Aiyar NV, Feuerstein GZ (1997) Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 28:155–161
Wang X, Siren AL, Liu Y, Yue TL, Barone FC, Feuerstein GZ (1994a) Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex. Brain Res Mol Brain Res 26:61–68
Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ (1994b) Concomitant cortical expression of TNF-α and IL-1 β mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 23:103–114
Wang X, Yue TL, White RF, Barone FC, Feuerstein GZ (1995a) Transforming growth factor-β1 exhibits delayed gene expression following focal cerebral ischemia. Brain Res Bull 36:607–609
Wang X, Yue TL, Young PR, Barone FC, Feuerstein GZ (1995b) Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J Cereb Blood Flow Metab 15:166–171
Weber C, Erl W, Pietsch A, Weber PC (1995) Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91:1914–1917
Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365–376
Winkler MK, Beveniste EN (1998) Transforming growth factor-β inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. Glia 22:171–179
Wong D, Dorovini-Zis K (1992) Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol 39:11–21
Wong D, Dorovini-Zis K (1996) Platelet/endothelial cell adhesion molecule-1 (PECAM-1) expression by human brain microvessel endothelial cells in primary culture. Brain Res 731:217–220
Wong ML, Bongiorno PB, Gold PW, Licinio J (1995) Localization of interleukin-1β converting enzyme mRNA in rat brain vasculature: evidence that the genes encoding the interleukin-1 system are constitutively expressed in brain blood vessels. Pathophysiological implications. Neuroimmunomodulation 2:141–148
Yabuuchi K, Minami M, Katsumata S, Satoh M (1994) Localization of type I interleukin-1 receptor mRNA in the rat brain. Brain Res Mol Brain Res 27:27–36
Yamasaki Y, Shozuhara H, Onodera H, Kogure K (1994) Blocking of interleukin-1 activity is a beneficial approach to ischemia brain edema formation. Acta Neurochir Suppl 60:300–302
Yang GY, Gong C, Qin Z, Ye W, Mao Y, Bertz AL (1998) Inhibition of TNFα attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport 9:2131–2134
Yang GY, Zhao YJ, Davidson BL, Betz AL (1997). Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res 751:181–188
Ye RD, Kravchenko VV, Pan Z, Feng L (1996) Stimulation of NF-κB activation and gene expression by platelet-activating factor. Adv Exp Med Biol 416:143–151
Yoshimoto T, Houkin K, Tada M, Abe H (1997) Induction of cytokines, chemokines and adhesion molecule mRNA in a rat forebrain reperfusion model. Acta Neuropathol (Berl) 93:154–158
Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769–15774
Zhai QH, Futrell N, Chen FJ (1997) Gene expression of IL-10 in relationship to TNF-α, IL-1β and IL- 2 in the rat brain following middle cerebral artery occlusion. J Neurol Sci 152:119–124
Zhang R, Chopp M, Zhang Z, Jiang N, Powers C (1998a) The expression of P- and E-selectins in three models of middle cerebral artery occlusion. Brain Res 785: 207–214
Zhang RL, Chopp M, Jiang N, Tang WX, Prostak J, Manning AM, Anderson DC (1995a) Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 27:1438–1442
Zhang RL, Chopp M, Zaloga C, Zhang ZG, Jiang N, Gautam SC, Tang WX, Tsang W, Anderson DC, Manning AM (1995b) The temporal profiles of ICAM-1 protein and mRNA expression after transient MCA occlusion in the rat. Brain Res 682: 182–188
Zhang RL, Chopp M, Zhang ZG, Phillips ML, Rosenbloom CL, Cruz R, Manning A (1996) E-selectin in focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab 16:1126–1136
Zhang Y, McCluskey K, Fujii K, Wahl LM (1998b) Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-α, granulocyte-macrophage CSF, and IL-1β through prostaglandin-dependent and -independent mechanisms. J Immunol 161:3071–3076
Zhang Z, Chopp M, Goussev A, Powers C (1998c) Cerebral vessels express interleukin 1β after focal cerebral ischemia. Brain Res 784:210–217
Zhang Z, Chopp M, Powers C (1997) Temporal profile of microglial response following transient (2h) middle cerebral artery occlusion. Brain Res 744:189–198
Zhang ZG, Chopp M, Tang WX, Jiang N, Zhang RL (1995c) Postischemic treatment (2–4h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2 h) focal cerebral ischemia in the rat. Brain Res 698:79–85
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Becker, K.J., Hallenbeck, J.M. (2002). Reducing Neuroinflammation. In: Marcoux, F.W., Choi, D.W. (eds) CNS Neuroprotection. Handbook of Experimental Pharmacology, vol 155. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06274-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-06274-6_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07625-1
Online ISBN: 978-3-662-06274-6
eBook Packages: Springer Book Archive